Pharmaceutical Science Research Center, Shahid Beheshti University of Medical Sciences
  • Register
  • Login
International Pharmacy Acta
  • Home
  • Journal Info
    • About the Journal
    • Publisher
    • Aim and Scope
    • Ownership & Management
    • Indexing and Abstracting
    • Editorial Team
    • Privacy Statement
    • Journal History
  • Issues
    • Current
    • Archives
  • For Authors
    • Author Guidelines
    • Types of articles
    • Templates
    • Publication Fees
    • Peer Review Process
  • For Reviewers
    • Reviewers' Guidelines
    • Responcibility for Reviewres
  • Publication Ethics
    • Publication Ethics and Malpractice Statement
    • Code of Publishing Ethics
  • Policies and Process
    • Allegations of Misconduct
    • Article Processing Charge (APC)
    • Advertisement and Marketing
    • Archiving
    • Article Withdrawal & Retraction Policy
    • Conflict of Interest
    • Copyright Notice
    • Complaints Policy
    • Editorial Policies
    • Open Access Policy
    • Peer-Review Policy
    • Post- Publication Discussions and Corrections Policy
    • Principles of Transparency
    • Publication Policy
    • Repository
    • Using Artificial Intelligence (AI) Plicies
  • New Submission
  • FAQ
  • Contact us
Advanced Search
  1. Home
  2. Archives
  3. Vol. 1 No. 1 (2018): Pharmacy Updates 2018 (Congress Proceeding)
  4. Supplementary Issues: Reviews of books, journal, congress, other media Special issues, and Scientific news

Vol. 1 No. 1 (2018)

March 2018

Chitosan Dextran Microparticles as the Potential Carrier for Colon Specific Delivery of 5- Fluorouracil

  • Soha Azadi
  • Amir Azadi
  • Hajar Ashrafi
  • Soliman Mohammadi-Samani

International Pharmacy Acta, Vol. 1 No. 1 (2018), 4 March 2018 , Page 76-77
https://doi.org/10.22037/ipa.v1i1.19937 Published: 2018-03-04

  • View Article
  • Download
  • Cite
  • Statastics
  • Share

Abstract

Introduction: Colorectal cancer is one of the most commonly diagnosed cancers in the world. The main and classic treatment of this cancer is 5-fluorouracil (5-Fu) that its cytotoxicity and low systemic absorption restricted its therapeutic efficacy. To overcome these problems, mucoadhesive and colonic microbially degradable formulations based on chitosan and dextran sulphate hydrogels could be effective.

Methods and Results: 5-Fu loaded hydrogel microparticles were formed via polyelectrolyte complexation technique using chitosan and dextran sulphate solutions. It was optimized by a systematic multi-objective optimization approach in terms of the particle size and loading efficiency of the resulting microparticles. Under this condition, the molecular weight of chitosan and 5-Fu concentration are the two factors which significantly influence the particle size and loading efficiency, respectively. Then the optimized microparticles were prepared and were characterized based on particle size, zeta potential, drug loading and drug release behavior. Finally the cytotoxicity of optimized microparticles was assessed by MTT assay (SW742 cell line) compare to free drug solution. Therefore, spherical particles of 51.33±0.95 μm mean diameter and a narrow size distribution were obtained under optimal conditions. The zeta potential, loading efficiency and loading capacity of optimized microparticles were 18.1±0.87mv, 26.96±0.38 and 13.12±0.65%, respectively. The in vitro drug release profile was fitted on Higuchi model and the cytotoxicity MTT results indicated the higher cytotoxicity of studied formulation on cells compare to free drug. The hydrogel microparticles were further lyophilized to prepare the enteric coated tablets and all tests endorsed that the coating process was suited.

Conclusions:

The designed formulations have provided appropriate properties and offer a potential mean for colon specific delivery of 5-Fu via oral administration.

Keywords:
  • 5-fluorouracil, Colon delivery, colorectal cancer, Drug release, Hydrogel
  • PDF

How to Cite

Azadi, S., Azadi, A., Ashrafi, H., & Mohammadi-Samani, S. (2018). Chitosan Dextran Microparticles as the Potential Carrier for Colon Specific Delivery of 5- Fluorouracil. International Pharmacy Acta, 1(1), 76–77. https://doi.org/10.22037/ipa.v1i1.19937
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
  • Endnote/Zotero/Mendeley (RIS)
  • BibTeX
  • Abstract Viewed: 331 times
  • PDF Downloaded: 225 times

Download Statastics

  • Linkedin
  • Twitter
  • Facebook
  • Google Plus
  • Telegram

Information

  • For Readers
  • For Authors
  • For Librarians

Make a Submission

Make a Submission
  • Home
  • Archives
  • Submissions
  • About the Journal
  • Editorial Team
  • Contact

Creative Commons License
This journal (and its contents) is licensed under a  Creative Commons Attribution-NonCommercial 4.0 International License.

 

                                                  Online ISSN: 2645-3266

                                                  Print ISSN: 2645-3258                                                 

Powered by OJSPlus